search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
163 new news items in the last 24 hours
  1. Home
  2. International

Novo Nordisk enters the US market with the oral weight loss pill Wegovy

Liviu Brăteanu
whatsapp
facebook
linkedin
x
copy-link copy-link
23 December 2025, 17:28
main event image
International
Foto: Pixabay
google-preference

Always see our news on Google

The U.S. Food and Drug Administration (FDA) has approved the weight loss pill developed by Novo Nordisk, giving the Danish company a significant advantage in the American obesity treatment market. The oral medication, which contains 25 mg of semaglutide – the same active ingredient in Wegovy and Ozempic – will be marketed under the Wegovy brand and is intended for the chronic management of weight in adults with obesity or overweight, marking a strategic step for Novo in direct competition with rival Eli Lilly.


Sources

sursa imagine
Profit.ro
Novo Nordisk intră în SUA cu pilula de slăbit
sursa imagine
Cotidianul
O nouă pilulă de slăbit obține aprobare în SUA

Latest News

18:14

CNAIR announces the opening of traffic on the A1 Tigveni–Curtea de Argeș / Drivers will travel through the first highway-bored tunnel in Romania

18:04

Cristela Georgescu sent a “clarification” message regarding the postponement of the Ilfov Tribunal’s decision in her husband’s case

17:56

Constantin Toma calls for changes to the public procurement law and a reduction in bureaucracy, warning that delays are blocking local investments

17:49

Radu Oprea reaffirms Romania’s support for Ukraine and calls for increased security in the Black Sea

17:39

An AfD leader invites Elon Musk to invest in the state of Saxony-Anhalt and promises “favorable conditions for business”

See more news

NEWS ON THE SAME TOPICS

event image
IT&C knowledge
The 2026 Nobel season opens today: Research on satiety hormones and weight-loss medications are the leading favorites for Medicine
event image
Health
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
event image
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
event image
International
Germany will provide €400 million to maintain Sanofi’s insulin production and reduce the risk of shortages in Europe
event image
Current Affairs
The Competition Council has launched an investigation and carried out unannounced inspections at the headquarters of pharmaceutical giant MSD in Romania
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
New Wegovy USA

Informat Moldova

main event image
Republic of Moldova
1 hour ago

Moldova’s Ministry of Defense announces two incursions by a Geran-2 drone into the country’s airspace

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa

Editor’s Recommendations

main event image
INSCOP Surveys
8 hours ago

NOVEMBER 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition - Chapter VIII: What would Romanians do with 1 million euros?

main event image
Exclusive
1 hour ago

ANALYSIS Brexit without profit: London seeks reconciliation with the EU

main event image
International
6 hours ago

ANALYSIS The Kerch Bridge, between Putin’s symbol and Crimea’s supply route. The stakes of the Ukrainian attacks

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol